Obesity Pill to Replace Injections

Novo Nordisk's high-dose experimental obesity pill, an oral version of semaglutide, helps overweight or obese adults lose 15% of their body weight when used with diet and exercise. Offering a more convenient alternative to injections, the pill could help individuals struggling to lose weight and address the significant health concern of obesity.